http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28235731

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 77
issn 1178-2048
pageRange 963-77
publicationName Vascular Health and Risk Management
startingPage 963
bibliographicCitation Abergel E, Nikolsky E. Ticagrelor: an investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome. Vasc Health Risk Manag. 2010 Oct 21;6():963–77. PMID: 21057581; PMCID: PMC2964949.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea58565c87ab807e7ca4dbc32dde3dee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_098b0e252de6767e039ef3aa68a531be
date 2010-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2964949
https://pubmed.ncbi.nlm.nih.gov/21057581
https://doi.org/10.2147/vhrm.s13263
isPartOf https://portal.issn.org/resource/ISSN/1178-2048
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33092
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Ticagrelor: An investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome
discusses http://id.nlm.nih.gov/mesh/M0513890
http://id.nlm.nih.gov/mesh/M0021526
http://id.nlm.nih.gov/mesh/M0000377
http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M0001864
http://id.nlm.nih.gov/mesh/M0155432
http://id.nlm.nih.gov/mesh/M0545456
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D010975Q000627
http://id.nlm.nih.gov/mesh/D000241Q000031
http://id.nlm.nih.gov/mesh/D054058Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D058925Q000187
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D013988Q000031
http://id.nlm.nih.gov/mesh/D000077144
http://id.nlm.nih.gov/mesh/D010975Q000009
http://id.nlm.nih.gov/mesh/D001792Q000187
http://id.nlm.nih.gov/mesh/D001241Q000627
http://id.nlm.nih.gov/mesh/D000241Q000627
http://id.nlm.nih.gov/mesh/D000241Q000009
http://id.nlm.nih.gov/mesh/D004417Q000139
http://id.nlm.nih.gov/mesh/D000077486
http://id.nlm.nih.gov/mesh/D054058Q000150
http://id.nlm.nih.gov/mesh/D013988Q000627
http://id.nlm.nih.gov/mesh/D016032
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f74135abcce785031995f1a87552cf78
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9871419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12210218
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243850853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247988848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248153327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128814610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129740296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136116304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129872283

Total number of triples: 70.